Contact
Name:
James Michael, PhD
Position:
Assistant Professor, Division of Hematology, Department of Medicine
Organization:
Sidney Kimmel Medical College
1020 Locust Street
Jefferson Alumni Hall 394
Philadelphia, PA 19107
Email:
James.Michael@jefferson.edu
Contact Number(s):
Publications
Publications
- P-Selectin(g) a diagnostic biomarker in heparin-induced thrombocytopenia
- Plasma growth factors maintain constitutive translation in platelets to regulate reactivity and thrombotic potential
- Activation of coagulation and proinflammatory pathways in thrombosis with thrombocytopenia syndrome and following COVID-19 vaccination
- Novel Strategy to Combat the Procoagulant Phenotype in Heparin-Induced Thrombocytopenia Using 12-LOX Inhibition
- Species Differences in Platelet Protease-Activated Receptors
- Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S
- Erratum: Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S (Blood Adv. (2023) 7: 2 (246-250) DOI: 10.1182/bloodadvances.2022007336)
- GRK2 regulates ADP signaling in platelets via P2Y1 and P2Y12
- Human and mouse PAR4 are functionally distinct receptors: Studies in novel humanized mice
- G protein–coupled receptor kinase 5 regulates thrombin signaling in platelets via PAR-1
- Platelet FcγRIIA in immunity and thrombosis: Adaptive immunothrombosis
- Regulation of ovarian cancer G protein-coupled receptor-1 expression and signaling
- Concepts and advances in cancer therapeutic vulnerabilities in RAS membrane targeting
- Bitter taste receptors for asthma therapeutics
- Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle
- Biased signaling of the proton-sensing receptor OGR1 by benzodiazepines
- Gα12 facilitates shortening in human airway smooth muscle by modulating phosphoinositide 3-kinase-mediated activation in a RhoA-dependent manner
- Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth
- Regulation of Ras signaling and function by plasma membrane microdomains
- Inhibition of galectin-1 sensitizes hras-driven tumor growth to rapamycin treatment